Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aquinox Pharmaceutic (AQXP)

Aquinox Pharmaceutic (AQXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aquinox Pharmaceutic 450-887 GREAT NORTHERN WAY VANCOUVER A1 V5T 4T5 CAN

www.aqxpharma.com P: 604-629-9223

Description:

Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company discovers and develops oral drug candidates to treat inflammation and cancer. Aquinox Pharmaceuticals, Inc. is headquartered in Vancouver, Canada.

Key Statistics

Overview:

Market Capitalization, $K 86,616
Shares Outstanding, K 23,537
Annual Sales, $ 25,000 K
Annual Net Income, $ -31,590 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ 0 K
60-Month Beta -7.37
% of Insider Shareholders 4.00%
% of Institutional Shareholders 71.69%
Float, K 22,596
% Float 96.00%

Growth:

1-Year Return 16.09%
3-Year Return -60.47%
5-Year Return -46.43%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 15.72%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 08/14/19
Earnings Per Share ttm -0.93
EPS Growth vs. Prev Qtr 100.00%
EPS Growth vs. Prev Year -100.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

AQXP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -30.13%
Return-on-Assets % -28.08%
Profit Margin % -126.36%
Debt/Equity 0.00
Price/Sales 3.27
Price/Cash Flow N/A
Price/Book 1.20
Book Value/Share 3.07
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar